European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Opinion/decision on a Paediatric investigation plan (PIP): Kapruvia, Difelikefalin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: EMA/PE/0000237641

Submitted by Anonymous (not verified) on 7 July 2026 - 12:57

Opinion/decision on a Paediatric investigation plan (PIP): Kapruvia, Difelikefalin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: EMA/PE/0000237641

Opinion/decision on a Paediatric investigation plan (PIP): Kerendia, finerenone, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiac disorders, PIP number: EMA/PE/0000241538

Submitted by Anonymous (not verified) on 7 July 2026 - 12:50

Opinion/decision on a Paediatric investigation plan (PIP): Kerendia, finerenone, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiac disorders, PIP number: EMA/PE/0000241538

20th anniversary of European Medicines Agency's Patients' and Consumers' Working Party (PCWP), Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 13:30 (CEST) to 30 June 2026, 17:30 (CEST)

Submitted by Anonymous (not verified) on 7 July 2026 - 12:20

20th anniversary of European Medicines Agency's Patients' and Consumers' Working Party (PCWP), Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 13:30 (CEST) to 30 June 2026, 17:30 (CEST)

PCWP/HCPWP joint meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 09:15 (CEST) to 1 July 2026, 12:00 (CEST)

Submitted by Anonymous (not verified) on 7 July 2026 - 12:00

PCWP/HCPWP joint meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 09:15 (CEST) to 1 July 2026, 12:00 (CEST)

Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 7 July 2026 - 11:20

Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 1, Status: Authorised

SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)

Submitted by Anonymous (not verified) on 7 July 2026 - 9:21

SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)

Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on training course using the EudraVigilance system, Bucharest, Romania, from 26 October 2026 to 28 October 2026

Submitted by Anonymous (not verified) on 7 July 2026 - 9:10

Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on training course using the EudraVigilance system, Bucharest, Romania, from 26 October 2026 to 28 October 2026

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness